daro

Search documents
IDEAYA Biosciences, Inc. (IDYA) Presents At Cantor Global Healthcare Conference 2025 Transcript
Seeking Alphaยท 2025-09-04 02:15
Core Insights - IDEAYA is emerging as a high-conviction investment opportunity within the biotech sector, particularly highlighted by recent developments and upcoming updates [1] - The company is expected to provide significant updates over the next six months, including pivotal data for its drug daro [1] Company Highlights - IDEAYA recently completed a significant deal, which has generated excitement among investors [1] - The company is preparing for its R&D Day and its 10th anniversary, indicating a milestone period for IDEAYA [1]